Offer - Urjas Oil for just ₹ 1 X
Megaparin is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Deep Vein Thrombosis. Secondary and off-label uses of Megaparin have also been mentioned below.
The correct dosage of Megaparin depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Megaparin also has some side effects, the most common being Dizziness, Headache. Some other side effects of Megaparin have been listed ahead. Normally, these side effects of Megaparin are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Megaparin's effect during pregnancy is Moderate and Mild while nursing. In addition, Megaparin's effects on the liver, heart and kidney are discussed below in the Megaparin related warnings section.
Megaparin is not recommended if you suffer from certain medical conditions as it can have adverse effects. Peptic Ulcer, Liver Disease, Hemophilia are examples of such conditions. Some other conditions that can be affected by Megaparin are listed in the contraindications section below.
Additionally, Megaparin may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Megaparin is considered safe while driving, and is addictive.
Megaparin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Neonates (0 to 1 month) |
|
Infant (1 month to 2 years) |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Megaparin safe for pregnant women?
Megaparin may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Megaparin again without your doctor's advice.
Is the use of Megaparin safe during breastfeeding?
Side effects of Megaparin on breastfeeding women are very mild.
What is the effect of Megaparin on the Kidneys?
Megaparin can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Megaparin on the Liver?
Megaparin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Megaparin on the Heart?
The heart can be affected by Megaparin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Megaparin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Megaparin unless your doctor advises you to do so -
Is this Megaparin habit forming or addictive?
No, there is no any evidence that Megaparin is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Megaparin does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Megaparin only on doctor's advice.
Is it able to treat mental disorders?
Megaparin is unable to treat or cure mental disorders.
Interaction between Food and Megaparin
Due to the absence of research, it is difficult to say how Megaparin and food will interact.
Interaction between Alcohol and Megaparin
Information about the interaction of Megaparin and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 638-640
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lovenox (enoxaparin sodium)